Applied DNA Sciences is a biotechnology company developing and commercializing technologies to produce and detect DNA and RNA. Using PCR to enable the production and detection of DNA and RNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics (including biologics and drugs) and, through our recent acquisition of Spindle Biotech, Inc. (“Spindle”), the development and sale of a proprietary RNA polymerase (“RNAP”) for use in the production of messenger RNA (“mRNA”) therapeutics (“Therapeutic DNA Production Services”); (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services (“MDx Testing Services”); and (iii) the manufacture and detection of DNA for industrial supply chain security services (“DNA Tagging and Security Products and Services”).
Our growth strategy is to primarily focus our resources on the further development, commercialization, and customer adoption of our Therapeutic DNA Production Services, including the expansion of our contract development and manufacturing operation (“CDMO”) for the manufacture of synthetic DNA for use in the production of nucleic acid-based therapies, and to further expand and commercialize our MDx Testing Services through genetic testing.
The Applied DNA Sciences Inc. corporate headquarters are located at:
50 Health Sciences Drive
Stony Brook, NY 11790
Tel +1-631-240-8800
Fax +1-631-240-8900
Applied DNA Sciences is a Delaware corporation.
Applied DNA Sciences fiscal year ends September 30.
Applied DNA Sciences common stock is traded on The NASDAQ Capital Market under the ticker symbol APDN.
Applied DNA Sciences warrants are traded on the OTC Markets under the ticker symbol APPDW.
Marcum LLP
10 Melville Park Road
Melville, NY
Tel: 631 414 4000
Fax: 631 414 4001
http://www.marcumllp.com
Equiniti Trust Company
Tel: (800) 937-5449 OR (718) 921-8124
URL: https://equiniti.com/us/ast-access/individuals/
The transfer agent is responsible for maintaining all records of stockholders (including change of address, telephone number, and name), canceling or issuing stock certificates, and resolving problems related to lost, destroyed, or stolen certificates.
No, Applied DNA Sciences does not offer a direct stock purchase plan. All purchases of stock must be made in the public market.
No, Applied DNA Sciences does not pay dividends at this time.
SEC filings are available at the following address: SEC Filings
Please contact
Sanjay M. Hurry
Executive Director, Investor Relations and Corporate Communications
E: sanjay.hurry@adnas.com
M: 917-733-5573